Figure 7. Schematic representation of FAK involvement in signaling pathways.
FAK can be activated in ischemic and hypoxic conditions; its downstream PI3K/AKT pathway is then activated through phosphorylation at the Tyr397 site, followed by mTOR/P70S6K activation. ERK1/2 can also be activated simultaneously. Both PI3K/AKT signalling and ERK1/2 are necessary for hypoxia-induced CF differentiation and ECM synthesis; this process also involves lysyl oxidase (LOX). Consequently, this response could be offset by FAK inhibitor.